298060 — SCM LifeScience Co Income Statement
0.000.00%
- KR₩27bn
- KR₩31bn
- KR₩825m
Annual income statement for SCM LifeScience Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | ARS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 320 | 439 | 396 | 696 | 825 |
Cost of Revenue | |||||
Gross Profit | 277 | 348 | 176 | 339 | 327 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 16,378 | 12,588 | 12,975 | 13,693 | 12,027 |
Operating Profit | -16,058 | -12,149 | -12,579 | -12,998 | -11,202 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -9,633 | -22,519 | -22,930 | -23,961 | -13,038 |
Provision for Income Taxes | |||||
Net Income After Taxes | -9,633 | -22,519 | -22,930 | -23,961 | -12,377 |
Net Income Before Extraordinary Items | |||||
Net Income | -9,633 | -22,519 | -22,930 | -23,961 | -12,377 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -9,633 | -22,519 | -22,930 | -23,961 | -12,377 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -674 | -1,393 | -1,404 | -1,464 | -600 |
Dividends per Share |